Anesthesia providers share how Accuro Neuraxial Guidance technology has reduced complications by over 80%, improving safety and efficiency in epidural and spinal placements.
Recent Posts
- RIVANNA Crosses 100-patent Threshold: Estate Protects Shared Platform Spanning Multiple FDA-cleared Product Lines
- RIVANNA Announces New CMS Procedure Code for Computer-aided Neuraxial Guidance
- The Inflection Point for Neuraxial Guidance
- Using AI to Strengthen Clinical Confidence: RIVANNA’s Will Mauldin on the Outcomes Rocket Podcast
- RIVANNA Receives FDA 510(k) Clearance for Accuro XV Musculoskeletal Ultrasound Imaging System
